CoChat

Effect of screening for Type 2 diabetes on population‐level self‐rated health outcomes and measures of cardiovascular risk: 13‐year follow‐up of the Ely cohort

Open access
Rahman, M., Simmons, R. K., Hennings, S. H., Wareham, N. J., Griffin, S. J. · 2012 · Diabetic Medicine
Cited by 30

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Diabet. Med. 29, 886–892 (2012) Aims There is continuing uncertainty regarding the overall net benefits of population‐based screening for Type 2 diabetes. We compared clinical measures, prescribed medication, cardiovascular morbidity and self‐rated health in individuals without diabetes in a screened vs. an unscreened population. Methods A parallel‐group, cohort study of people aged 40–65 years, free of known diabetes, identified from the population register of a general practice in Ely, Cambridgeshire (n = 4936). In 1990–1992, one third (n = 1705), selected randomly, received an invitation for screening for diabetes and cardiovascular risk factors at 5‐yearly intervals (screened population). From the remainder of the sampling frame, 1705 randomly selected individuals were invited to diabetes screening 10 years later (unscreened population). Patients without known diabetes from both populations were invited for a health assessment. Results Of 3390 eligible individuals without diabetes, 1442 (43%) attended for health assessment, with no significant difference in attendance between groups. Thirteen years after the commencement of screening, self‐rated functional health status and health utility were identical between the screened and unscreened populations. Clinical measures, self‐reported medication and cardiovascular morbidity were similar between the two groups. Conclusions Screening for diabetes is not associated with long‐term harms at the population level. However, screening has limited long‐term impact on those testing negative; benefits may largely be restricted to those whose diabetes is detected early through screening.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2012.03570.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 30

Metadata

Authors
Rahman, M., Simmons, R. K., Hennings, S. H., Wareham, N. J., & Griffin, S. J.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2012-06-19
Volume
29
Issue
7
Pages
886-892
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1867693824
Cited by
30
References
5
FWCI
3.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of screening for Type 2 diabetes on population‐level self‐rated health outcomes and measures of cardiovascular risk: 13‐year follow‐up of the Ely cohort. https://app.cochat.ai/papers/10.1111/j.1464-5491.2012.03570.x
The paper
Rahman, M., Simmons, R. K., Hennings, S. H., Wareham, N. J., & Griffin, S. J. (2012). Effect of screening for Type 2 diabetes on population‐level self‐rated health outcomes and measures of cardiovascular risk: 13‐year follow‐up of the Ely cohort. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2012.03570.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.